Hot Investor Mandate: Taiwan VC Firm Seeks Cross-Border Investment Opportunities with Strong Interests in Therapeutics and Digital Health

24 Oct

A Taiwan-based VC with additional offices in USA has invested primarily in Taiwanese companies, but actively considers those based in the US as well. The firm invests primarily in therapeutics and digital health. The firm looks to be an active investor, and can help those companies looking to expand to the US. The firm invests early, in seed-early stage rounds, and generally makes a first investment of between $500K-1M.

The firm primarily invests in therapeutics and digital health, although will consider investing in medical devices or diagnostics if the company is exceptional. For therapeutics technology, the firm is agnostic to indication and will invest as early as proof of concept stage, although some animal data is preferable. For digital health companies, the firm is fairly flexible with regards to stage of development and will consider most healthcare-related or IoT technologies (e.g. smart hospital applications).

The firm looks for companies with great teams, whether they are experienced entrepreneurs or not. For companies based in Taiwan, the firm prefers to lead investments and take a board seat, playing an active role after investment. For US-based companies, the firm will generally co-invest and may recommend a partner to the board.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: